Shandong Kexing Bioproducts Co. Ltd. A (688136 SHG) stock market data APIs
¥37.037
0.46(1.2%)
as of November 7, 2025
Try our APIs with
free plan!
Shandong Kexing Bioproducts Co. Ltd. A Financial Data Overview
Price chart is built with
Anychart
Kexing Biopharm Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia. The company focuses on oncology, immunology, and degenerative diseases; and develops new antibodies, proteins, nucleic acid drugs, and antiviral therapy, as well as for the treatment of tumor, autoimmune, metabolic diseases, and other therapeutic fields. It also develops GB05 human interferon a1b inhalation solution that is in Phase III clinical trial; GB-K02, an human granulocyte colony-stimulating factor injection in Phase III clinical trial; GB08, an growth hormone that has completed Phase I clinical trial; GB10 for fundus diseases; GB12 for atopic dermatitis; GB18 for cancer cachexia; GB23 for solid tumors; GB24 for inflammatory bowel diseases; and GB25, an tri-specific antibody for colorectal cancer. In addition, the company's products include drugs, such as human erythropoietin, human interferon a1b and human granulocyte colony-stimulating factor injections, albumin-bound paclitaxel, infliximab injection, combined clostridium butyricum, and bifidobacterium powder/capsule. Kexing Biopharm Co., Ltd. was founded in 1997 and is based in Jinan, China.
Prev. Close
37.037
Open
37.4969
High
37.3818
Low
36.6518
52 wk Range
16.1874-63.2764
Market Cap
7 424 M
P/E Ratio
58.5556
Shares Outstanding
201 M
Revenue
1 516 M
EPS
-0.0441
Dividends (Yield)
0.0021
Beta
0.768
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shandong Kexing Bioproducts Co. Ltd. A data using free add-ons & libraries
Get Shandong Kexing Bioproducts Co. Ltd. A Fundamental Data
Shandong Kexing Bioproducts Co. Ltd. A Fundamental data includes:
- Net Revenue: 1 516 M
- EBITDA: 192 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-03-31
- EPS/Forecast: NaN
Get Shandong Kexing Bioproducts Co. Ltd. A End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shandong Kexing Bioproducts Co. Ltd. A News
New
IQVIA Holdings (IQV) Announces CFO Transition With Michael Fedock Succeeding Ron Bruehlman
IQVIA Holdings recently appointed Michael Fedock as the future CFO, replacing the retiring Ron Bruehlman, marking a significant leadership transition. The company's shares rose 29% last quarter, a per...
IQVIA Holdings (IQV) Enters Partnership With Kexing Biopharm To Enhance Drug Development
IQVIA Holdings recently forged a strategic partnership with Kexing Biopharm, aiming to bolster the clinical development and market integration of innovative therapeutics globally. Over the last quarte...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
